We have measured increment thresholds for a 4.1 cycfdeg grating in 24 de-novo patients (Hoehn and Yahr stage I to 111) with idiopathic (IPS) and 9 patients with nonidiopathic parkinson syndrome (N-IPS) and for comparison 26 age-matched normal controls. Patients with positive L-Dopa and apomorphine
Smoking and cognitive function in Parkinson's disease
✍ Scribed by Marc G. Weisskopf; Francine Grodstein; Alberto Ascherio
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 98 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The risk of dementia among Parkinson's disease (PD) patients is greatly elevated compared to controls, yet little is known about determinants of cognitive function among PD patients. We assessed the relation between cigarette smoking prior to disease onset and later cognitive function among PD patients (n = 286) and age‐ and sex‐matched controls (n = 1144) participating in the Nurses' Health Study and Health Professionals Follow‐up Study. Both groups completed telephone‐administered assessments of cognitive function. We used linear regression to calculate mean differences in cognitive test scores across smoking categories, adjusted for age, education, sex, age at onset of PD, and years since diagnosis. PD patients scored significantly worse on all tests than their matched controls. In analyses only among PD cases, but not among controls, current smokers at PD onset scored worse than never smokers on the Telephone Interview for Cognitive Status (difference = −0.82, 95% CI: −1.33, −0.30, P = 0.002) as well as on a global score combining results of all tests (difference = −0.36, 95% CI: −0.72, 0.01, P = 0.06). This difference was equivalent to the difference in global score observed among controls ∼10 years apart in age. Analyses of pack‐years of smoking prior to disease onset gave similar results. These findings, nested in prospective cohort studies, suggest that cigarette smoking prior to disease onset is associated with worse cognitive function in PD. © 2007 Movement Disorder Society
📜 SIMILAR VOLUMES
The negative association between smoking and the risk of Parkinson's disease (PD) has been a controversial issue since it was first reported by Dorn in 1959. 1 Recent meta-analysis of prospective studies showed that smoking protects against PD with pooled relative risk of 0.51 (95% confidence interv
## Abstract Patients with Parkinson's disease (PD) may present impairment in cognitive functions even at early stages of the disease. When compared with the general population, their risk of dementia is five to six times higher. Recent investigations using structural MRI have shown that dementia in
Nonmotor symptoms have recently become a focus of renewed clinical interest and research in Parkinson's disease (PD). Autonomic and cognitive dysfunction are among the most prevalent of these nonmotor aspects of the disease. Although exact clinico-pathological correlations have not been established,
## Abstract Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based o